
Ph.D. candidate at Centre for Systems Biology, Samuel Lunenfeld Research Institute
Toronto, Canada Area

Ph.D. candidate at Centre for Systems Biology, Samuel Lunenfeld Research Institute
Toronto, Canada Area
(Educational Institution; Biotechnology industry)
September 2002 — Present (5 years 11 months)
Mike Tyers' lab, Centre for Systems Biology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, ON
(Public Company; Pharmaceuticals industry)
January 2002 — May 2002 (5 months)
Apoptosis Group, Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Kirkland, QC
(Public Company; Pharmaceuticals industry)
May 2001 — August 2001 (4 months)
Apoptosis Group, Department of Biochemistry and Molecular Biology, Merck Frosst Centre for Therapeutic Research, Kirkland, QC
(Government Agency; Biotechnology industry)
September 2000 — December 2000 (4 months)
Human Parvovirus B19 Group, Division of Blood-borne Pathogens, Health Canada, Canadian Science Centre for Human and Animal Health, Winnipeg, MB
(Public Company; Pharmaceuticals industry)
January 2000 — April 2000 (4 months)
Human Immunodeficiency Virus (HIV) Group, Department of Biological Sciences, Boehringer Ingelheim (Canada) Ltd., Bio-Méga Research Division, Laval, QC
(Public Company; Pharmaceuticals industry)
January 1999 — April 1999 (4 months)
Human Papillomavirus (HPV) Group, Department of Biological Sciences, Boehringer Ingelheim (Canada) Ltd., Bio-Méga Research Division, Laval, QC
Ph.D., Molecular Genetics, 2002 — 2009 (expected)
B.Sc., Specialized Honours Co-op Biochemistry, 1997 — 2001